SEC Form 4 · accession 0001209191-18-019619
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Pepia
Officer — Principal Accounting Officer
Period of report
Mar 13, 2018
Accepted (ET)
Mar 14, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2018 | M | 3,000 | $27.715 | A | 39,716 | D | |
| Common StockF2 | Mar 13, 2018 | S | 3,000 | $58.3542 | D | 36,716 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $27.715 | Mar 13, 2018 | M | 3,000 | A | Jun 2, 2011 | Jun 2, 2018 | Common Stock | 3,000 | 3,000 | D |
Explanation of responses
- F1Sales made pursuant to Reporting Person's 105b-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $57.85 to $58.79 for a weighted average sales price of $58.3542. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares at each separate price within the range set forth in this footnote.